- Home
- MNKD vs HEPS Comparison
MNKD vs HEPS Comparison
Compare MNKD & HEPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNKD | HEPS |
|---|---|---|
| Founded | 1991 | 2000 |
| Country | United States | Turkey |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 877.0M | 948.0M |
| IPO Year | 2004 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MNKD | HEPS |
|---|---|---|
| Price | $3.52 | $2.76 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | ★ $8.69 | $3.07 |
| AVG Volume (30 Days) | ★ 6.3M | 382.8K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $348,966,000.00 | N/A |
| Revenue This Year | $35.81 | $41.29 |
| Revenue Next Year | $11.89 | $27.99 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 22.23 | N/A |
| 52 Week Low | $2.23 | $2.15 |
| 52 Week High | $6.51 | $3.30 |
Technical Indicators
Market Signals| Indicator | MNKD | HEPS |
|---|---|---|
| Relative Strength Index (RSI) | 64.71 | 52.42 |
| Support Level | $2.45 | $2.52 |
| Resistance Level | $6.08 | $2.93 |
| Average True Range (ATR) | 0.26 | 0.10 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 43.01 | 72.39 |
Price Performance
Historical ComparisonAbout MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.
About HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues and other revenues.